Back | Next |
home / stock / lexx / lexx message board
Subject | By | Source | When |
---|---|---|---|
NetworkNewsWire: NetworkNewsBreaks Lexaria Bioscience Corp. (NASDAQ: LEXX) Expanding Portfolio with | NetworkNewsWire | investorshangout | 04/20/2023 7:33:22 PM |
Thanks Shawking -- eom | harlem111 | investorshub | 04/20/2023 4:10:50 PM |
Lexaria is Receiving Four New Patents | Shawking | investorshub | 04/20/2023 3:36:35 PM |
$LEXX oh yeah news for the day | harlem111 | investorshub | 04/20/2023 5:19:26 AM |
He is conman. How come Altria didn't pay | all4weed | investorshub | 04/20/2023 3:09:44 AM |
One of my worst ever investments too. Appalled | Nosnibor | investorshub | 04/19/2023 7:53:38 PM |
Yep -- no repricing. of course they will | harlem111 | investorshub | 04/19/2023 4:57:45 PM |
VOTE NO on repricing options. Management has consistently | Tech99989 | investorshub | 04/19/2023 4:10:54 AM |
$LEXX Good read | PotsandPans420 | investorshub | 04/19/2023 1:30:41 AM |
NetworkNewsWire: Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes the Licensed Use of its DehydraTECH(TM | NetworkNewsWire | investorshangout | 04/17/2023 8:13:28 PM |
this bd shows the pps at 1.69... | harlem111 | investorshub | 04/16/2023 11:44:39 PM |
NetworkNewsWire: NetworkNewsBreaks Lexaria Bioscience Corp.s (NASDAQ: LEXX) DehydraTECH(TM) Demonst | NetworkNewsWire | investorshangout | 04/14/2023 8:30:54 PM |
Ted sure hasnt given up hope | PotsandPans420 | investorshub | 04/11/2023 11:29:43 AM |
Ted Ohashi-Let's Toke Business | Shawking | investorshub | 04/11/2023 12:24:22 AM |
NetworkNewsWire: Lexaria Bioscience Corp. (NASDAQ: LEXX) Revolutionizing Drug Delivery Potential for | NetworkNewsWire | investorshangout | 04/10/2023 8:25:16 PM |
Yea I just would think he would have | PotsandPans420 | investorshub | 04/09/2023 2:44:08 AM |
As we look towards 2022 and 2023, Lexaria | Shawking | investorshub | 04/08/2023 4:08:15 AM |
Why would a former President At GWPH come | PotsandPans420 | investorshub | 04/06/2023 10:54:10 PM |
hope you are well. Another raise - no | harlem111 | investorshub | 04/06/2023 6:31:45 PM |
Hows everyone doing here. Its been awhile | PotsandPans420 | investorshub | 04/06/2023 3:43:00 PM |
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
3.3%Change Percent:
Lexaria Bioscience Corp. Company Name:
LEXX Stock Symbol:
NASDAQ Market:
Lexaria Bioscience Corp. Website:
Lexaria, a global innovator in drug delivery platforms, recently completed dosing of its human pilot study #2, GLP-1-H24-2 The study is to explore the tolerability, side effects, and blood levels of semaglutide, a glucagon-like peptide-1 (“GLP-1”) drug For Lexaria, the results f...
Lexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global innovator in drug delivery platforms, today announced the receipt of interim results from the first four weeks of dosing in its ongoing diabetes animal study WEIGHT-A24-1. The company noted that the results have already produced several notewort...
(TheNewswire) DehydraTECH appears to work with a second GLP-1 drug – liraglutide DehydraTECH appears to be working with semaglutide both with and without SNAC technology DehydraTECH-CBD is showing strong apparent performance relative to GLP-1 D...